Principal Financial Group
JAZZ icon

Principal Financial Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Principal Financial Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.3M Buy
142,414
+6,910
+5% +$1.51M 0.02% 690
2026
Q1 		$25.6M Buy
135,504
+4,907
+4% +$858K 0.01% 771
2025
Q4 		$22.2M Sell
130,597
-4,041
-3% -$620K 0.01% 837
2025
Q3 		$17.7M Sell
134,638
-5,015
-4% -$602K 0.01% 938
2025
Q2 		$14.8M Buy
139,653
+612
+0.4% +$66.5K 0.01% 1032
2025
Q1 		$17.3M Buy
139,041
+378
+0.3% +$49.3K 0.01% 923
2024
Q4 		$17.1M Sell
138,663
-4,275
-3% -$504K 0.01% 954
2024
Q3 		$15.9M Sell
142,938
-66,821
-32% -$7.32M 0.01% 983
2024
Q2 		$22.4M Sell
209,759
-27,684
-12% -$3.04M 0.01% 788
2024
Q1 		$28.6M Buy
237,443
+5,066
+2% +$621K 0.02% 703
2023
Q4 		$28.6M Sell
232,377
-1,779
-0.8% -$222K 0.02% 664
2023
Q3 		$30.3M Sell
234,156
-7,381
-3% -$984K 0.02% 572
2023
Q2 		$29.9M Sell
241,537
-7,516
-3% -$1.01M 0.02% 625
2023
Q1 		$36.4M Buy
249,053
+2,227
+0.9% +$329K 0.03% 531
2022
Q4 		$39.3M Sell
246,826
-4,581
-2% -$671K 0.03% 487
2022
Q3 		$33.5M Sell
251,407
-64,030
-20% -$9.74M 0.03% 514
2022
Q2 		$49.2M Buy
315,437
+71,450
+29% +$11M 0.04% 412
2022
Q1 		$38M Buy
243,987
+33,759
+16% +$4.9M 0.02% 556
2021
Q4 		$26.8M Sell
210,228
-2,615
-1% -$344K 0.02% 747
2021
Q3 		$27.7M Sell
212,843
-56,449
-21% -$8.53M 0.02% 691
2021
Q2 		$47.8M Buy
269,292
+75,134
+39% +$13M 0.03% 464
2021
Q1 		$31.9M Buy
194,158
+29,142
+18% +$4.8M 0.02% 608
2020
Q4 		$27.2M Buy
165,016
+163
+0.1% +$24.3K 0.02% 607
2020
Q3 		$23.5M Buy
164,853
+160,348
+3,559% +$19.9M 0.02% 591
2020
Q2 		$497K Sell
4,505
-4,138
-48% -$458K ﹤0.01% 1971
2020
Q1 		$862K Buy
8,643
+1,112
+15% +$144K ﹤0.01% 1757
2019
Q4 		$1.12M Buy
7,531
+905
+14% +$123K ﹤0.01% 1812
2019
Q3 		$849K Sell
6,626
-6
-0.1% -$804 ﹤0.01% 1851
2019
Q2 		$945K Sell
6,632
-2,241
-25% -$301K ﹤0.01% 1850
2019
Q1 		$1.27M Buy
8,873
+1,063
+14% +$139K ﹤0.01% 1799
2018
Q4 		$968K Sell
7,810
-1,402
-15% -$208K ﹤0.01% 1814
2018
Q3 		$1.55M Buy
9,212
+815
+10% +$140K ﹤0.01% 1786
2018
Q2 		$1.45M Buy
+8,397
New +$1.37M ﹤0.01% 1792
2016
Q2 		– Sell
-10,640
Closed -$1.39M – 2189
2016
Q1 		$1.39M Buy
10,640
+694
+7% +$86.4K ﹤0.01% 1687
2015
Q4 		$1.4M Sell
9,946
-1,210
-11% -$168K ﹤0.01% 1707
2015
Q3 		$1.48M Buy
11,156
+5,853
+110% +$1.01M ﹤0.01% 1710
2015
Q2 		$934K Buy
5,303
+537
+11% +$96.4K ﹤0.01% 1794
2015
Q1 		$824K Sell
4,766
-12,404
-72% -$2.13M ﹤0.01% 1793
2014
Q4 		$2.81M Buy
17,170
+11,707
+214% +$1.94M ﹤0.01% 1606
2014
Q3 		$877K Sell
5,463
-851
-13% -$131K ﹤0.01% 1777
2014
Q2 		$928K Buy
+6,314
New +$876K ﹤0.01% 1801
2014
Q1 		– Sell
-4,244
Closed -$537K – 2286
2013
Q4 		$537K Sell
4,244
-2,715
-39% -$281K ﹤0.01% 1870
2013
Q3 		$640K Sell
6,959
-776
-10% -$62.6K ﹤0.01% 1810
2013
Q2 		$532K Buy
+7,735
New +$473K ﹤0.01% 1819

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.17B AUM 36.16% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

Principal Financial Group's JAZZ Position: Q2 2026 in Review

Principal Financial Group increased its Jazz Pharmaceuticals (JAZZ) stake by 5.1% in Q2 2026, buying an estimated $1.51M and bringing the position to 142,414 shares worth $34.3M. The position accounts for 0.02% of the portfolio, ranked #690.

Principal Financial Group first reported a position in JAZZ in Q2 2013 and has held it in 44 quarters since. The position peaked at $49.2M in Q2 2022. 311 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Principal Financial Group held 142,414 shares of Jazz Pharmaceuticals worth $34.3M as of Q2 2026.
  • Principal Financial Group bought 6,910 Jazz Pharmaceuticals shares in Q2 2026, an estimated $1.51M.
  • Jazz Pharmaceuticals made up 0.02% of Principal Financial Group's portfolio in Q2 2026, its #690 holding.
  • Principal Financial Group first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 44 quarters since.
  • Principal Financial Group's Jazz Pharmaceuticals position peaked at $49.2M in Q2 2022.
  • 311 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.